Image Source : The Hans India
Talbros Automotive Components Limited, along with its JVs, has won multi-year orders worth over ₹1,000 crore across gaskets, heat shields, forgings, chassis, hoses and anti-vibration parts from top domestic and global OEMs. The orders, including significant export and EV business, will be executed over five years with commercialization from FY27.
Show more
Talbros Automotive Components Limited (TACL), a leading Indian auto component manufacturer, has announced a significant business win of over ₹1,000 crore in cumulative multi-year orders from both domestic and international OEMs. These orders enhance long-term revenue visibility, strengthen its export portfolio, and deepen its presence in high-potential EV and European markets.
Spanning the company’s complete product basket gaskets, heat shields, forging components, chassis parts, hoses and anti-vibration components the contracts are scheduled to be executed over the next five years, with commercialization commencing in FY27. The wins come through TACL and its joint ventures, underlining the group’s growing technological and manufacturing capabilities across specialized automotive segments.
Key Highlights
-
Orders worth ~₹250 crore from the sealing business (gaskets and heat shields), including ~₹110 crore in exports.
-
Export orders of ~₹500 crore in the forgings business, with a large share from a newly onboarded Europe-based global auto component major.
-
Export orders of ~₹90 crore via JV Marelli Talbros Chassis Systems for BIW chassis components for luxury vehicles and SUVs in the EV segment.
-
Domestic orders of ~₹170 crore through JV Talbros Marugo Rubber for hoses and anti-vibration parts.
-
Around ₹700 crore of the total order book linked to exports and ~₹100 crore attributable to the EV segment.
-
Execution timeline: next five years, with product commercialization from FY27, supporting improved profitability and market share in Europe.
Sources: Talbros Automotive Components Limited
Stay Ahead – Explore Now!
Novo Nordisk CEO Defends Wegovy Pill Pricing as a Responsibility, Not a Gamble
Advertisement
Advertisement